NCT02728622View on ClinicalTrials.gov

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2009

Conditions
Ovarian CancerPeritoneal CancerCancer of the Fallopian Tube
Interventions
DRUG

Tamoxifen

endocrine treatment

DRUG

Chemotherapy

Paclitaxel or pegylated liposomal doxorubicin

All Listed Sponsors
lead

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

OTHER

NCT02728622 - Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane | Biotech Hunter | Biotech Hunter